X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (116) 116
female (115) 115
middle aged (69) 69
index medicus (60) 60
aged (56) 56
adult (53) 53
oncology (51) 51
ovarian cancer (47) 47
obstetrics & gynecology (45) 45
ovarian neoplasms - genetics (43) 43
cancer (40) 40
risk factors (34) 34
genetic predisposition to disease (32) 32
neoplasm staging (28) 28
ovarian neoplasms - pathology (28) 28
risk (28) 28
aged, 80 and over (27) 27
polymorphism, single nucleotide (24) 24
prognosis (24) 24
carcinoma (23) 23
genotype (20) 20
article (19) 19
genome-wide association study (19) 19
carcinoma, ovarian epithelial (18) 18
case-control studies (17) 17
genetics & heredity (16) 16
genome-wide association (16) 16
ovarian neoplasms - metabolism (16) 16
research (16) 16
breast-cancer (15) 15
endocrine system diseases (15) 15
expression (15) 15
genetic aspects (15) 15
neoplasms, glandular and epithelial - genetics (15) 15
obstetrics and gynecology (14) 14
adolescent (13) 13
female genital diseases and pregnancy complications (13) 13
survival (13) 13
endometrial cancer (11) 11
endometrial neoplasms - pathology (11) 11
gene expression regulation, neoplastic (11) 11
hematology, oncology and palliative medicine (11) 11
immunohistochemistry (11) 11
oncology, experimental (11) 11
ovarian neoplasms - epidemiology (11) 11
retrospective studies (11) 11
breast cancer (10) 10
chemotherapy (10) 10
finland - epidemiology (10) 10
ovarian neoplasms - drug therapy (10) 10
tumors (10) 10
women (10) 10
disease-free survival (9) 9
endometrial carcinoma (9) 9
finland (9) 9
gene (9) 9
genes (9) 9
genetic variation (9) 9
metaanalysis (9) 9
multivariate analysis (9) 9
ovarian neoplasms (9) 9
ovarian neoplasms - surgery (9) 9
treatment outcome (9) 9
cystadenocarcinoma, serous - pathology (8) 8
follow-up studies (8) 8
gene expression profiling (8) 8
health aspects (8) 8
incidence (8) 8
mutation (8) 8
ovarian neoplasms - blood (8) 8
polymorphism, single nucleotide - genetics (8) 8
prospective studies (8) 8
surgery (8) 8
young adult (8) 8
adenocarcinoma (7) 7
age factors (7) 7
alleles (7) 7
biomarkers, tumor - genetics (7) 7
ca-125 antigen - blood (7) 7
cohort studies (7) 7
genetics (7) 7
granulosa cell tumor - pathology (7) 7
hysterectomy (7) 7
identification (7) 7
management (7) 7
medicin och hälsovetenskap (7) 7
neoplasm invasiveness (7) 7
paclitaxel (7) 7
survival rate (7) 7
variants (7) 7
3122 cancers (6) 6
3123 gynaecology and paediatrics (6) 6
adenocarcinoma - pathology (6) 6
analysis (6) 6
animals (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
biomarkers, tumor - blood (6) 6
common variants (6) 6
cystadenocarcinoma, serous - genetics (6) 6
cystadenocarcinoma, serous - metabolism (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Bojesen, Stig E and Pooley, Karen A and Johnatty, Sharon E and Beesley, Jonathan and Michailidou, Kyriaki and Tyrer, Jonathan P and Edwards, Stacey L and Pickett, Hilda A and Shen, Howard C and Smart, Chanel E and Hillman, Kristine M and Mai, Phuong L and Lawrenson, Kate and Stutz, Michael D and Lu, Yi and Karevan, Rod and Woods, Nicholas and Johnston, Rebecca L and French, Juliet D and Chen, Xiaoqing and Weischer, Maren and Nielsen, Sune F and Maranian, Melanie J and Ghoussaini, Maya and Ahmed, Shahana and Baynes, Caroline and Bolla, Manjeet K and Wang, Qin and Dennis, Joe and McGuffog, Lesley and Barrowdale, Daniel and Lee, Anew and Healey, Sue and Lush, Michael and Tessier, Daniel C and Vincent, Daniel and Bacot, Françis and Vergote, Ignace and Lambrechts, Sanina and Despierre, Evelyn and Risch, Harvey A and González-Neira, Anna and Rossing, Mary Anne and Pita, Guillermo and Doherty, Jennifer A and Alvarez, Nuria and Larson, Melissa C and Fridley, Brooke L and Schoof, Nils and Chang-Claude, Jenny and Cicek, Mine S and Peto, Julian and Kalli, Kimberly R and Broeks, Annegien and Armasu, Sebastian M and Schmidt, Marjanka K and Braaf, Linde M and Winterhoff, Boris and Nevanlinna, Heli and Konecny, Gottfried E and Lambrechts, Diether and Rogmann, Lisa and Guénel, Pascal and Teoman, Attila and Milne, Roger L and Garcia, Joaquin J and Cox, Angela and Shridhar, Vijayalakshmi and Burwinkel, Barbara and Marme, Frederik and Hein, Rebecca and Sawyer, Elinor J and Haiman, Christopher A and Wang-Gohrke, Shan and Anulis, Irene L and Moysich, Kirsten B and Hopper, John L and Odunsi, Kunle and Lindblom, Annika and Giles, Graham G and Brenner, Hermann and Simard, Jacques and Lurie, Galina and Fasching, Peter A and Carney, Michael E and Radice, Paolo and Wilkens, Lynne R and Swerdlow, Anthony and Goodman, Marc T and Brauch, Hiltrud and Garcia-Closas, Montserrat and Hillemanns, Peter and Winqvist, Robert and Dürst, Matthias and Devilee, Peter and Runnebaum, Ingo and Jakubowska, Anna and Lubinski, Jan and Mannermaa, Arto and Butzow, Ralf and ... and Gene Environm Interactimi Breast and Kathleen Cuningham Fdn Consortium and Australian Ovarian Canc Study and Epidemiological Study BRCA1 and Hereditary Breast Ovarian Canc Res and Genetic Modifiers Canc Risk BRCA1 and Australian Canc Study and Swedish Breast Canc Study SWE-BRCA and The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) and Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO) and Gene Environment Interaction and Breast Cancer (GENICA) and Swedish Breast Cancer Study (SWE-BRCA) and Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE) and Australian Ovarian Cancer Study and Australian Cancer Study and Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab) and Medicinska fakulteten and Umeå universitet and Institutionen för strålningsvetenskaper
Nature genetics, ISSN 1061-4036, 2013, Volume 45, Issue 4, pp. 371 - 384
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 26, pp. 2484 - 2496
The addition of bevacizumab to chemotherapy (15 mg/kg for six cycles) followed by extended therapy with bevacizumab every 3 weeks for a total of 15 months of... 
CARBOPLATIN-PACLITAXEL | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INTERGROUP TRIAL | GYNECOLOGIC-ONCOLOGY-GROUP | SOLID TUMORS | ANGIOGENESIS | CYCLOPHOSPHAMIDE | EXPRESSION | INTRAPERITONEAL CISPLATIN | III TRIAL | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carboplatin - administration & dosage | Combined Modality Therapy | Ovarian Neoplasms - mortality | Neoplasms, Glandular and Epithelial - surgery | Bevacizumab | Disease-Free Survival | Neoplasms, Glandular and Epithelial - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Angiogenesis Inhibitors - therapeutic use | Carcinoma, Ovarian Epithelial | Quality of Life | Female | Paclitaxel - administration & dosage | Angiogenesis Inhibitors - adverse effects | Ovarian Neoplasms - drug therapy | Ovarian Neoplasms - surgery | Drugs | Dose-response relationship (Biochemistry) | Product/Service Evaluations | Drug therapy | Ovarian cancer | Risk groups | Body weight | Clinical trials | Survival | Angiogenesis | Chemotherapy | Womens health | Paclitaxel | Carboplatin | Vascular endothelial growth factor | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
International Journal of Gynecological Cancer, ISSN 1048-891X, 06/2015, Volume 25, Issue 5, pp. 837 - 842
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2014, Volume 111, Issue 42, pp. 15172 - 15177
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2008, Volume 105, Issue 19, pp. 7004 - 7009
Journal Article
by Kuchenbaecker, K.B and Ramus, S.J and Tyrer, J and Lee, A and Shen, H.C and Beesley, J and Lawrenson, K and McGuffog, L and Healey, S and Lee, J.M and Spindler, T.J and Lin, Y.G and Pejovic, T and Bean, Y and Li, Q and Coetzee, S and Hazelett, D and Miron, A and Southey, M and Terry, M.B and Goldgar, D.E and Buys, S.S and Janavicius, R and Dorfling, C.M and Rensburg, E.J. van and Neuhausen, S.L and Ding, Y.C and Hansen, T.V and Jonson, L and Gerdes, A.M and Ejlertsen, B and Barrowdale, D and Dennis, J and Benitez, J and Osorio, A and Garcia, M.J and Komenaka, I and Weitzel, J.N and Ganschow, P and Peterlongo, P and Bernard, L and Viel, A and Bonanni, B and Peissel, B and Manoukian, S and Radice, P and Papi, L and Ottini, L and Fostira, F and Konstantopoulou, I and Garber, J and Frost, D and Perkins, J and Platte, R and Ellis, S and Embrace and Godwin, A.K and Schmutzler, R.K and Meindl, A and Engel, C and Sutter, C and Sinilnikova, O.M and Damiola, F and Mazoyer, S and Stoppa-Lyonnet, D and Claes, K and Leeneer, K. De and Kirk, J and Roiguez, G.C and Piedmonte, M and O'Malley, D.M and Hoya, M. de la and Caldes, T and Aittomaki, K and Nevanlinna, H and Collee, J.M and Rookus, M.A and Oosterwijk, J.C and Tihomirova, L and Tung, N and Hamann, U and Isaccs, C and Tischkowitz, M and Imyanitov, E.N and Caligo, M.A and Campbell, I.G and Hogervorst, F.B and Olah, E and Diez, O and Blanco, I and Brunet, J and Lazaro, C and Pujana, M.A and Jakubowska, A and Gronwald, J and Lubinski, J and Sukiennicki, G and Massuger, L.F.A.G and Altena, A.M. van and Aben, K.K.H and ... and KConFab Investigators and EMBRACE and GEMO Study Collaborators and Breast Cancer Family Registry and Australian Ovarian Canc Study Grp and HEBON and Consortium Invest Modifiers BRCA1 and Australian Canc Study Ovarian Canc and Australian Cancer Study (Ovarian Cancer Investigators) and Australian Ovarian Cancer Study Group and Consortium of Investigators of Modifiers of BRCA1 and BRCA2 and the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 and Region Östergötland and Linköpings universitet and Institutionen för klinisk och experimentell medicin and Diagnostikcentrum and Klinisk patologi och klinisk genetik and Avdelningen för kliniska vetenskaper and Hälsouniversitetet
Nature Genetics, ISSN 1061-4036, 2015, Volume 47, Issue 2, pp. 164 - 171
Journal Article
Methods in Molecular Biology, ISSN 1064-3745, 2009, Volume 472, pp. 387 - 396
Primary fallopian tube carcinoma (PFTC) is a rare malignancy, but its incidence has been rising during the last decades and varies between 2.9/1,000,000 and... 
Sociodemographic determinants | Human papillomavirus | Chlamydia trachomatis | Parity | Primary fallopian tube carcinoma | Sterilization | Fallopian Tube Neoplasms - epidemiology | Fallopian Tube Neoplasms - prevention & control | Humans | Risk Factors | Female | Finland - epidemiology | Socioeconomic Factors | Incidence
Conference Proceeding
by Goode, E.L and Chenevix-Trench, G and Song, H and Ramus, S.J and Notaridou, M and Lawrenson, K and Widschwendter, M and Vierkant, R.A and Larson, M.C and Kjaer, S.K and Birrer, M.J and Berchuck, A and Schildkraut, J and Tomlinson, I.P and Kiemeney, L.A.L.M and Cook, L.S and Gronwald, J and Garcia-Closas, M and Gore, M.E and Campbell, I and Whittemore, A.S and Sutphen, R and Phelan, C.M and Anton-Culver, H and Pearce, C.L and Lambrechts, D and Rossing, M.A and Chang-Claude, J and Moysich, K.B and Goodman, M.T and Dork, T and Nevanlinna, H and Ness, R.B and Rafnar, T and Hogdall, E and Fridley, B.L and Cunningham, J.M and Sieh, W and McGuire, V and Godwin, A.K and Cramer, D.W and Hernandez, D and Levine, D and Lu, K and Iversen, E.S and Palmieri, R.T and Houlston, R.S and Altena, A.M. van and Aben, K.K.H and Massuger, L.F.A.G and Brooks-Wilson, A and Kelemen, L.E and Le, N.D and Jakubowska, A and Lubinski, J and Meek, K and Stafford, A and Easton, D.F and Tyrer, J.P and Bolton, K.L and Harrington, P and Eccles, D and Chen, A and Molina, A.N and Davila, B.N and Arango, H and Tsai, Y.Y and Chen, Z and Risch, H.A and McLaughlin, J and Narod, S and Ziogas, A and Brewster, W and Gentry-Maharaj, A and Menon, U and Wu, A.H and Stram, D.O and Pike, M.C and Beesley, J and Webb, P.M and Chen, X and Ekici, A.B and Thiel, F.C and Beckmann, M.W and Yang, H and Wentzensen, N and Lissowska, J and Fasching, P.A and Despierre, E and Amant, F and Vergote, I and Doherty, J and Hein, R and Wang-Gohrke, S and Lurie, G and Carney, M.E and Thompson, P and OCAC and Wellcome Trust Case-Control Conso and Australian Ovarian Canc Study Grp and Australian Canc Study Ovarian Canc and Australian Ovarian Cancer Study Group and Wellcome Trust Case-Control Consortium and Australian Cancer Study (Ovarian Cancer) and Ovarian Cancer Association Consortium (OCAC) and the Ovarian Cancer Association Consortium (OCAC) and The Wellcome Trust Case-Control Consortium and The Australian Ovarian Cancer Study Group and The Australian Cancer Study (Ovarian Cancer)
Nature Genetics, ISSN 1061-4036, 2010, Volume 42, Issue 10, pp. 874 - 879
Journal Article